Top compounds associated with response to CD99L2


Feature Type Standardized
Nominal ANOVA
mRNA Bexarotene GDSC1000 pan-cancer AAC 0.13 0.0007
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0007
mRNA Erlotinib CCLE pan-cancer AAC -0.16 0.0007
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.12 0.0008
mRNA OSI-027 GDSC1000 pan-cancer AAC -0.11 0.0008
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA Midostaurin GDSC1000 pan-cancer AAC 0.13 0.001
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA GSK2126458 GDSC1000 pan-cancer AAC -0.11 0.001
Download CSV